Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 147 participants.
Also called NCT01493999
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 147 participants
- Sponsor
- University of Pecs
- Registry
-
NCT01493999
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Hungary
- Registry status
- Completed
Technical summary
Registry record NCT01493999. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2013-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity
- Acronym
- TREAT-HPR
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Clopidogrel reloading
- Intervention (Drug)
- Prasugrel
- Lead sponsor
- University of Pecs
Record details
- Record id
cardio:ct-nct01493999- Content hash
b04fd5056a9a6f4dbacdc3a507bb3424413db35b43dbe47d1635a43e338929fe